This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Hologic (HOLX) Outpaced the Stock Market Today
by Zacks Equity Research
Hologic (HOLX) closed at $58.84 in the latest trading session, marking a +1.71% move from the prior day.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic (HOLX) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Hologic (HOLX) concluded the recent trading session at $61.27, signifying a +0.67% move from its prior day's close.
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock?
by Moumi Mondal
HOLX's diagnostics strength, robust international potential and new board addition support its "Hold" case. Yet, ongoing global uncertainties remain a drag.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Hologic (HOLX) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Hologic (HOLX) reachead $61.77 at the closing of the latest trading day, reflecting a +0.73% change compared to its last close.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic (HOLX) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the most recent trading session, Hologic (HOLX) closed at $61.89, indicating a +0.68% shift from the previous trading day.
New Product Launches to Support HOLX Stock Amid Macro Issues
by Zacks Equity Research
Hologic's Surgical business has been driving strong broad-based performance by expanding access to technologies in new global markets.
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?
by Moumi Mondal
As Hologic works through the changing macroeconomic and geopolitical landscape, its long-term potential makes it a solid hold.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
by Zacks Equity Research
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic (HOLX) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Hologic (HOLX) closed at $61.82, marking a +1.83% move from the previous day.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
QuidelOrtho Unveils Results Manager System to Streamline Testing
by Zacks Equity Research
QDEL introduces the Results Manager System, a powerful tool designed to streamline diagnostic data management, enhance efficiency, and improve patient care.
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report?
by Zacks Equity Research
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic Wins Key Approvals Post Q1 Results: Buy or Hold HOLX Stock?
by Moumi Mondal
HOLX's latest regulatory successes draw investors' attention. However, macroeconomic challenges restrict its full growth potential.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Do Options Traders Know Something About Hologic (HOLX) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Hologic (HOLX) stock based on the movements in the options market lately.
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes
by Zacks Equity Research
Hologic's Surgical business has been recording strong broad-based performance by expanding access to technologies into new global markets.
Here's Why You Should Retain HOLX Stock in Your Portfolio Now
by Zacks Equity Research
Hologic's strength in the molecular diagnostics wing instills optimism among investors. Yet, a dull macroeconomic environment raises concerns.
Deciphering Hologic (HOLX) International Revenue Trends
by Zacks Equity Research
Examine the evolution of Hologic's (HOLX) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's Why Hologic (HOLX) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance
by Zacks Equity Research
HOLX's fiscal 2025 first-quarter results reflect the strength of its Molecular Diagnostics business.